Zareparsi S - Search Results

1

Exclusion of dominant mutations within the FTDP-17 locus on chromosome 17 for Parkinson's disease.

Zareparsi S, Wirdefeldt K, Burgess CE, Nutt J, Kramer P, Schalling M, Payami H. Zareparsi S, et al. Neurosci Lett. 1999 Sep 10;272(2):140-2. doi: 10.1016/s0304-3940(99)00581-9. Neurosci Lett. 1999. PMID: 10507561

2

Age at onset of Parkinson disease and apolipoprotein E genotypes.

Zareparsi S, Camicioli R, Sexton G, Bird T, Swanson P, Kaye J, Nutt J, Payami H. Zareparsi S, et al. Am J Med Genet. 2002 Jan 15;107(2):156-61. doi: 10.1002/ajmg.10111. Am J Med Genet. 2002. PMID: 11807891

3

Segregation analysis of Parkinson disease.

Zareparsi S, Taylor TD, Harris EL, Payami H. Zareparsi S, et al. Am J Med Genet. 1998 Dec 4;80(4):410-7. doi: 10.1002/(sici)1096-8628(19981204)80:4<410::aid-ajmg21>3.0.co;2-2. Am J Med Genet. 1998. PMID: 9856574

4

Genetic epidemiology of Parkinson's disease.

Payami H, Zareparsi S. Payami H, et al. Among authors: zareparsi s. J Geriatr Psychiatry Neurol. 1998 Summer;11(2):98-106. doi: 10.1177/089198879801100207. J Geriatr Psychiatry Neurol. 1998. PMID: 9877530 Review.

5

Familial aggregation of Parkinson disease: a comparative study of early-onset and late-onset disease.

Payami H, Zareparsi S, James D, Nutt J. Payami H, et al. Among authors: zareparsi s. Arch Neurol. 2002 May;59(5):848-50. doi: 10.1001/archneur.59.5.848. Arch Neurol. 2002. PMID: 12020270

6

Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes.

Zareparsi S, Kaye J, Camicioli R, Grimslid H, Oken B, Litt M, Nutt J, Bird T, Schellenberg G, Payami H. Zareparsi S, et al. Ann Neurol. 1997 Oct;42(4):655-8. doi: 10.1002/ana.410420417. Ann Neurol. 1997. PMID: 9382478

7

Parkinson's disease, CYP2D6 polymorphism, and age.

Payami H, Lee N, Zareparsi S, Gonzales McNeal M, Camicioli R, Bird TD, Sexton G, Gancher S, Kaye J, Calhoun D, Swanson PD, Nutt J. Payami H, et al. Among authors: zareparsi s. Neurology. 2001 May 22;56(10):1363-70. doi: 10.1212/wnl.56.10.1363. Neurology. 2001. PMID: 11376189

8

Analysis of the alpha-synuclein G209A mutation in familial Parkinson's disease.

Zareparsi S, Kaye J, Camicioli R, Kramer P, Nutt J, Bird T, Litt M, Payami H. Zareparsi S, et al. Lancet. 1998 Jan 3;351(9095):37-8. doi: 10.1016/s0140-6736(05)78089-2. Lancet. 1998. PMID: 9433434 No abstract available.

9

Identification of genetic modifiers of age-at-onset for familial Parkinson's disease.

Hill-Burns EM, Ross OA, Wissemann WT, Soto-Ortolaza AI, Zareparsi S, Siuda J, Lynch T, Wszolek ZK, Silburn PA, Mellick GD, Ritz B, Scherzer CR, Zabetian CP, Factor SA, Breheny PJ, Payami H. Hill-Burns EM, et al. Among authors: zareparsi s. Hum Mol Genet. 2016 Sep 1;25(17):3849-3862. doi: 10.1093/hmg/ddw206. Epub 2016 Jul 11. Hum Mol Genet. 2016. PMID: 27402877 Free PMC article.

10

HLA-A2 homozygosity but not heterozygosity is associated with Alzheimer disease.

Zareparsi S, James DM, Kaye JA, Bird TD, Schellenberg GD, Payami H. Zareparsi S, et al. Neurology. 2002 Mar 26;58(6):973-5. doi: 10.1212/wnl.58.6.973. Neurology. 2002. PMID: 11914421

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters